Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-12-27

FDA Approved: GLIMEPIRIDE — Supplemental Application (Rising Pharma Holdings, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for glimepiride submitted by Rising Pharma Holdings, Inc., expanding the regulatory status of this generic diabetes …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Glimepiride (glimepiride)

Snippet

SUPPL AP for GLIMEPIRIDE (GLIMEPIRIDE)